Ir al contenido
· Rellenos dérmicos
SKU 11052 · GTIN 4046222013455

Radiesse

En stock
Volumen
1 x 1.5mL
Laboratorio
Merz Aesthetics
Origen
Estados Unidos
Indicación
Moderate to deep facial folds, facial volume loss
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.

Radiesse is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, designed for deep dermal and sub-dermal soft tissue augmentation with a 27G needle. Its gel carrier dissipates in vivo, replaced by soft tissue growth, while the calcium hydroxylapatite stays in place, for long-term but non-permanent restoration and augmentation. By weight it is 56% synthetic CaHA particles (25 to 45 microns) and 44% carrier of sterile water for injection, glycerin and sodium carboxymethylcellulose. One pre-filled 1.5 mL syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single person, single treatment use.

Principales ventajas de Radiesse

  • Synthetic calcium hydroxylapatite implant, a different product class from a hyaluronic acid filler
  • 56% CaHA particles and 44% gel carrier by weight, with a particle size of 25 to 45 microns
  • The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the CaHA remains at the injection site
  • A lifetime of at least 12 months across every approved indication, as a demonstrated minimum rather than an expected end point
  • Highly viscoelastic, well suited to sub-dermal and deep dermal placement for a considerable volumising effect
  • Can be diluted 1:2 with sterile saline for larger areas such as the décolleté
  • Supplied sterile in a sealed foil pouch as one 1.5 mL syringe with two 27G thin-wall needles
  • CE marked under EU MDR 2017/745 via notified body 0123, supplied with a patient Implant Card
  • Manufactured by Merz Aesthetics in the USA
Información clave
Marca RADIESSE
Fabricante Merz Aesthetics
País de origen United States
Certificación CE marked in accordance with Regulation (EU) 2017/745. Supplied with a patient Implant Card. Basic UDI-DI 018629500DF30001LK; the Summary of Safety and Clinical Performance is available via EUDAMED at ec.europa.eu/tools/eudamed
Composición Synthetic calcium hydroxylapatite (CaHA) particles, 25-45 microns, suspended in a gel carrier of sterile water for injection, glycerin and sodium carboxymethylcellulose. By weight 56% CaHA particles and 44% gel carrier, the gel comprising 36.0% sterile water for injection, 6.6% glycerin and 1.4% sodium carboxymethylcellulose. Non-animal-based and free from animal protein
Volumen / Tamaño 1.5 ml
Envase One pre-filled 1.5 mL syringe with a Terumo K-Pack II containing two 27G thin-wall injection needles, supplied sterile in a sealed foil pouch. Single person, single treatment use
Tamaño de la aguja 27G thin-wall needle with a standard Luer fitting; two needles supplied in the pack
Tipo de uso For professional use - qualified practitioners and clinics only
Profundidad de inyección Deep dermal and sub-dermal soft tissue augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement
Protocolo / Duración A lifetime of at least a year or more in most persons, with at least 12 months for every approved indication: nasolabial folds, cheek augmentation, hand augmentation, facial fat loss in people with HIV, and moderate to severe decollete wrinkles. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the patient, the area treated, the volume placed and the injection technique

Indicaciones y uso profesional

Indicaciones principales

  • Treatment of nasolabial folds
  • Augmentation of the cheeks
  • Hand augmentation to correct volume loss in the dorsum of the hands
  • Restoration and correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus
  • Moderate and severe décolleté wrinkles, when diluted 1:2 with 0.9% sterile saline

Uso profesional

Radiesse is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is intended for single-person, single-treatment use only, for deep dermal and sub-dermal soft tissue augmentation. Injection technique, plane and volume are determined by the treating practitioner on a per-patient basis. Introduction of the implant into the vasculature may lead to embolisation or thrombosis, occlusion of the vessels, ischaemia or infarction, so particular care is required when injecting soft tissue fillers. The product must not be re-sterilised, and must not be used if the foil pouch is compromised or the syringe damaged.

Zonas de tratamiento

  • Nasolabial folds
  • Cheeks
  • Dorsum of the hands
  • Areas of facial fat loss (lipoatrophy) in people with HIV
  • Décolleté, when diluted 1:2 with 0.9% sterile saline
  • Not intended for the glabellar folds or the nose area, where a higher incidence of localised necrosis has been associated with injection

Perfil del paciente

Suitable for adult patients assessed as appropriate by the treating practitioner. Radiesse is contraindicated in the presence of acute or chronic inflammation or infection involving the area to be treated; in persons with severe allergies manifested by a history of anaphylaxis, or a history or presence of multiple severe allergies; in persons with known hypersensitivity to any of the components; in persons prone to developing inflammatory skin conditions or with a tendency to develop hypertrophic scars and keloids; in persons with bleeding disorders; and during pregnancy and in breastfeeding females. It must not be implanted in the epidermis or used as a skin replacement, and is not intended for correction of the glabellar folds or the nose area. For hand augmentation, the safety of injection into the dorsum of the hand has not been studied in persons under 26 or over 79 years of age, volumes over 3 mL per hand in a treatment session have not been studied, and safety beyond one year in the hand has not been investigated in clinical trials.

Cómo funciona Radiesse ​

Radiesse is composed of synthetic calcium hydroxylapatite microspheres, 25 to 45 microns in size, suspended in a gel carrier of sterile water, glycerin and sodium carboxymethylcellulose. The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, producing a long-term yet non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement, where it delivers a considerable volumising effect. Diluting the implant makes it less viscous and therefore more suitable for rejuvenation of larger areas such as the décolleté.

Por qué comprar en Allpara

Allpara ofrece productos RADIESSE originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

How does Radiesse work?

The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection. The result is a long-term but non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement and delivers a considerable volumising effect.

How long does Radiesse last?

Radiesse has a lifetime of at least a year or more in most persons, with at least 12 months across every approved indication: nasolabial folds, augmentation of the cheeks, hand augmentation, facial fat loss in people with HIV, and moderate to severe décolleté wrinkles. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the individual patient, the area treated, the volume placed and the injection technique used.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
RADIESSE
Laboratorio
Merz Aesthetics
SKU
11052
GTIN
4046222013455
Formato
1 x 1.5mL
Origen
Estados Unidos
Indicación
Moderate to deep facial folds, facial volume loss
Uso
Professional use, qualified practitioners
/ Detalles del producto

El expediente completo

Radiesse is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, designed for deep dermal and sub-dermal soft tissue augmentation with a 27G needle. Its gel carrier dissipates in vivo, replaced by soft tissue growth, while the calcium hydroxylapatite stays in place, for long-term but non-permanent restoration and augmentation. By weight it is 56% synthetic CaHA particles (25 to 45 microns) and 44% carrier of sterile water for injection, glycerin and sodium carboxymethylcellulose. One pre-filled 1.5 mL syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single person, single treatment use.

Merz Aesthetics, país de origen Estados Unidos.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

How does Radiesse work?

The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection. The result is a long-term but non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement and delivers a considerable volumising effect.

How long does Radiesse last?

Radiesse has a lifetime of at least a year or more in most persons, with at least 12 months across every approved indication: nasolabial folds, augmentation of the cheeks, hand augmentation, facial fat loss in people with HIV, and moderate to severe décolleté wrinkles. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the individual patient, the area treated, the volume placed and the injection technique used.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

How does Radiesse work?
The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection. The result is a long-term but non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement and delivers a considerable volumising effect.
How long does Radiesse last?
Radiesse has a lifetime of at least a year or more in most persons, with at least 12 months across every approved indication: nasolabial folds, augmentation of the cheeks, hand augmentation, facial fat loss in people with HIV, and moderate to severe décolleté wrinkles. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the individual patient, the area treated, the volume placed and the injection technique used.
/ FAQ

Preguntas frecuentes

The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection. The result is a long-term but non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement and delivers a considerable volumising effect.
Radiesse has a lifetime of at least a year or more in most persons, with at least 12 months across every approved indication: nasolabial folds, augmentation of the cheeks, hand augmentation, facial fat loss in people with HIV, and moderate to severe décolleté wrinkles. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the individual patient, the area treated, the volume placed and the injection technique used.

Más productos de Merz

Ver laboratorio

Alternativas para la clínica

Todos los productos

Radiesse

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Radiesse is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, designed for deep dermal and sub-dermal soft tissue augmentation with a 27G needle. Its gel carrier dissipates in vivo, replaced by soft tissue growth, while the calcium hydroxylapatite stays in place, for long-term but non-permanent restoration and augmentation. By weight it is 56% synthetic CaHA particles (25 to 45 microns) and 44% carrier of sterile water for injection, glycerin and sodium carboxymethylcellulose. One pre-filled 1.5 mL syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single person, single treatment use.

Principales ventajas de Radiesse

  • Synthetic calcium hydroxylapatite implant, a different product class from a hyaluronic acid filler
  • 56% CaHA particles and 44% gel carrier by weight, with a particle size of 25 to 45 microns
  • The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the CaHA remains at the injection site
  • A lifetime of at least 12 months across every approved indication, as a demonstrated minimum rather than an expected end point
  • Highly viscoelastic, well suited to sub-dermal and deep dermal placement for a considerable volumising effect
  • Can be diluted 1:2 with sterile saline for larger areas such as the décolleté
  • Supplied sterile in a sealed foil pouch as one 1.5 mL syringe with two 27G thin-wall needles
  • CE marked under EU MDR 2017/745 via notified body 0123, supplied with a patient Implant Card
  • Manufactured by Merz Aesthetics in the USA
Información clave
Marca RADIESSE
Fabricante Merz Aesthetics
País de origen United States
Certificación CE marked in accordance with Regulation (EU) 2017/745. Supplied with a patient Implant Card. Basic UDI-DI 018629500DF30001LK; the Summary of Safety and Clinical Performance is available via EUDAMED at ec.europa.eu/tools/eudamed
Composición Synthetic calcium hydroxylapatite (CaHA) particles, 25-45 microns, suspended in a gel carrier of sterile water for injection, glycerin and sodium carboxymethylcellulose. By weight 56% CaHA particles and 44% gel carrier, the gel comprising 36.0% sterile water for injection, 6.6% glycerin and 1.4% sodium carboxymethylcellulose. Non-animal-based and free from animal protein
Volumen / Tamaño 1.5 ml
Envase One pre-filled 1.5 mL syringe with a Terumo K-Pack II containing two 27G thin-wall injection needles, supplied sterile in a sealed foil pouch. Single person, single treatment use
Tamaño de la aguja 27G thin-wall needle with a standard Luer fitting; two needles supplied in the pack
Tipo de uso For professional use - qualified practitioners and clinics only
Profundidad de inyección Deep dermal and sub-dermal soft tissue augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement
Protocolo / Duración A lifetime of at least a year or more in most persons, with at least 12 months for every approved indication: nasolabial folds, cheek augmentation, hand augmentation, facial fat loss in people with HIV, and moderate to severe decollete wrinkles. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the patient, the area treated, the volume placed and the injection technique

Indicaciones y uso profesional

Indicaciones principales

  • Treatment of nasolabial folds
  • Augmentation of the cheeks
  • Hand augmentation to correct volume loss in the dorsum of the hands
  • Restoration and correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus
  • Moderate and severe décolleté wrinkles, when diluted 1:2 with 0.9% sterile saline

Uso profesional

Radiesse is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is intended for single-person, single-treatment use only, for deep dermal and sub-dermal soft tissue augmentation. Injection technique, plane and volume are determined by the treating practitioner on a per-patient basis. Introduction of the implant into the vasculature may lead to embolisation or thrombosis, occlusion of the vessels, ischaemia or infarction, so particular care is required when injecting soft tissue fillers. The product must not be re-sterilised, and must not be used if the foil pouch is compromised or the syringe damaged.

Zonas de tratamiento

  • Nasolabial folds
  • Cheeks
  • Dorsum of the hands
  • Areas of facial fat loss (lipoatrophy) in people with HIV
  • Décolleté, when diluted 1:2 with 0.9% sterile saline
  • Not intended for the glabellar folds or the nose area, where a higher incidence of localised necrosis has been associated with injection

Perfil del paciente

Suitable for adult patients assessed as appropriate by the treating practitioner. Radiesse is contraindicated in the presence of acute or chronic inflammation or infection involving the area to be treated; in persons with severe allergies manifested by a history of anaphylaxis, or a history or presence of multiple severe allergies; in persons with known hypersensitivity to any of the components; in persons prone to developing inflammatory skin conditions or with a tendency to develop hypertrophic scars and keloids; in persons with bleeding disorders; and during pregnancy and in breastfeeding females. It must not be implanted in the epidermis or used as a skin replacement, and is not intended for correction of the glabellar folds or the nose area. For hand augmentation, the safety of injection into the dorsum of the hand has not been studied in persons under 26 or over 79 years of age, volumes over 3 mL per hand in a treatment session have not been studied, and safety beyond one year in the hand has not been investigated in clinical trials.

Cómo funciona Radiesse ​

Radiesse is composed of synthetic calcium hydroxylapatite microspheres, 25 to 45 microns in size, suspended in a gel carrier of sterile water, glycerin and sodium carboxymethylcellulose. The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, producing a long-term yet non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement, where it delivers a considerable volumising effect. Diluting the implant makes it less viscous and therefore more suitable for rejuvenation of larger areas such as the décolleté.

Por qué comprar en Allpara

Allpara ofrece productos RADIESSE originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

How does Radiesse work?

The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection. The result is a long-term but non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement and delivers a considerable volumising effect.

How long does Radiesse last?

Radiesse has a lifetime of at least a year or more in most persons, with at least 12 months across every approved indication: nasolabial folds, augmentation of the cheeks, hand augmentation, facial fat loss in people with HIV, and moderate to severe décolleté wrinkles. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the individual patient, the area treated, the volume placed and the injection technique used.

Más productos de Merz

Ver el laboratorio →

Radiesse is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, designed for deep dermal and sub-dermal soft tissue augmentation with a 27G needle. Its gel carrier dissipates in vivo, replaced by soft tissue growth, while the calcium hydroxylapatite stays in place, for long-term but non-permanent restoration and augmentation. By weight it is 56% synthetic CaHA particles (25 to 45 microns) and 44% carrier of sterile water for injection, glycerin and sodium carboxymethylcellulose. One pre-filled 1.5 mL syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single person, single treatment use.

Merz Aesthetics, país de origen Estados Unidos.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

How does Radiesse work?

The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection. The result is a long-term but non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to sub-dermal and deep dermal placement and delivers a considerable volumising effect.

How long does Radiesse last?

Radiesse has a lifetime of at least a year or more in most persons, with at least 12 months across every approved indication: nasolabial folds, augmentation of the cheeks, hand augmentation, facial fat loss in people with HIV, and moderate to severe décolleté wrinkles. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the individual patient, the area treated, the volume placed and the injection technique used.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.